Mind Medicine (MindMed) Inc. MNMD announced that the FDA granted a breakthrough therapy designation to its lead candidate, MM120 (lysergide D-tartrate) for treating generalized anxiety disorder (GAD)....
Source LinkMind Medicine (MindMed) Inc. MNMD announced that the FDA granted a breakthrough therapy designation to its lead candidate, MM120 (lysergide D-tartrate) for treating generalized anxiety disorder (GAD)....
Source Link
Comments